Serial Low Doses of Sorafenib Enhance Therapeutic Efficacy of Adoptive T Cell Therapy in a Murine Model by Improving Tumor Microenvironment
PLoS ONE - United States
doi 10.1371/journal.pone.0109992
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 15, 2014
Authors
Publisher
Public Library of Science (PLoS)